Filing Details
- Accession Number:
- 0001035267-25-000198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-29 13:02:33
- Reporting Period:
- 2025-07-28
- Filing Date:
- 2025-07-29
- Accepted Time:
- 2025-07-29 13:02:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1035267 | Intuitive Surgical Inc | ISRG | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 770416458 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1280628 | S Gary Guthart | 1020 Kifer Road Sunnyvale CA 94086 | Executive Chair Of The Board O | Yes | Yes | No | No |
Transaction Summary
Sold: | 10,693 shares | Avg. Price: $497.75 | Total Value: $5,322,418.81 |
Number of Shares After Transactions: | 1,204,863 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-07-28 | 7,893 | $59.46 | 21,080 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-07-28 | 7,893 | $498.64 | 13,187 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-07-28 | 1,400 | $495.23 | 18,520 | No | 4 | S | Indirect | Trust FBO Daughter |
Common Stock | Disposition | 2025-07-28 | 1,400 | $495.24 | 18,520 | No | 4 | S | Indirect | Trust FBO Son |
Common Stock | Disposition | 2025-07-28 | 10,500 | $0.00 | 1,204,863 | No | 4 | G | Indirect | by Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | Trust FBO Daughter |
No | 4 | S | Indirect | Trust FBO Son |
No | 4 | G | Indirect | by Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2025-07-28 | 7,893 | $0.00 | 7,893 | $59.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2026-02-16 | No | 4 | M | Direct |
Footnotes
- The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $494.33 to $500.00 as follows: 475 shares sold at $494.33 to $495.16; 202 shares sold at $495.79 to $496.62; 1,045 shares sold at $496.81 to $496.87; 1,996 shares sold at $498.06 to $499.00; and 4,175 shares sold at $499.20 to $500.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $493.85 to $496.31 as follows: 527 shares sold at $493.85 to $494.81; 569 shares sold at $494.97 to $495.72; and 304 shares sold at $496.00 to $496.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $493.85 to $496.31 as follows: 320 shares sold at $493.85 to $494.85; 806 shares sold at $494.87 to $495.62; and 274 shares sold at $496.00 to $496.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The shares were donated to a Donor Advised Fund (DAF) in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026.
- Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.